206. 脆弱Ｘ症候群 Fragile X syndrome Clinical trials / Disease details
臨床試験数 : 104 / 薬物数 : 87 - (DrugBank : 32) / 標的遺伝子数 : 54 - 標的パスウェイ数 : 79
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT01254045 (ClinicalTrials.gov) | February 2007 | 2/12/2010 | Double-blind Placebo Controlled Study of Oxytocin in Fragile X Syndrome | Double-blind Placebo Controlled Study of Oxytocin in Fragile X Syndrome | Fragile X Syndrome | Drug: placebo;Drug: oxytocin 24IU;Drug: oxytocin 48IU | Stanford University | NULL | Completed | 13 Years | 29 Years | Male | 10 | Phase 2 | United States |